Biotech

All Articles

Biogen's chief executive officer pointed out no risky deals in 2023. He's ready to become vibrant

.While Biogen's pharma peers are actually seeking for late-stage possessions along with little dange...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has actually been a biotech looking for a pipe after it scrapped its own lead resources ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored civil liberties to a very early Alzheimer's ailment program to Denali ...

Takeda touches brand new head of US oncology service-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Vertex, beaten through AATD again, drops 2 assets on throw away heap

.Tip's attempt to handle a rare hereditary ailment has reached another trouble. The biotech threw pa...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter profits file wasn't except significant information. The provider...

Galapagos stops briefly CAR-T cell therapy litigation over Parkinsonism situation

.Galapagos has paused registration in a trial of a BCMA-directed CAR-T cell treatment, pushing the b...

James Wilson leaving behind Penn to launch pair of brand-new biotechs

.After greater than 30 years, genetics therapy innovator James Wilson M.D., Ph.D., is leaving behind...

3 biotechs make an effort to beat the summer months heat energy by dropping staff

.As biotechs seek to transform a new web page in August, at least three providers have shed personne...

venBio elevates $528M for 5th lifestyle sciences VC fund

.Expert financial backing agency venBio has actually raised an additional half a billion bucks to pu...